infections, 22% autoimmune related diseases, 22% cancer, 17% healthcare-acquired infections (HAIs), and 13% genetic-related diseases. Tyler Radke, MLS(ASCP),


Tyler Radke, MLS(ASCP)


Team Leader, Laboratory, Bellin Memorial Hospital, Bellin Health Oconto Hospital, Oconto, Wis., said while overall testing for COVID-19 has receded over the past year in his lab, testing re- mains active for symptomatic patients and unvaccinated pre- procedural cases. He states:


“Overall laboratory testing remains above pre- pandemic levels with what seems to constitute delayed services during the pandemic and new growth occurring within our system. The volumes that are presently challenging us are not specifi c to one department but mostly constitute Chemistry, Hematology, Microbiology, and Surgical Pathology. Some of the volume challenges we are hoping to address via improved order utilization and future laboratory automation.” “The testing volume has become very unpre- dictable,” said Nassreen Fontanilla, QA/LIS Lab Supervisor, Northern Nevada Health System,


MLO-ONLINE.COM AUGUST 2022


29


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52